BTS
WST icon

BB&T Securities’s West Pharmaceutical WST Stock Holding History

BB&T Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$260K Sell
1,835
-88
-5% -$12.1K ﹤0.01% 1385
2019
Q2 		$240K Buy
+1,923
New +$227K ﹤0.01% 1429

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

BB&T Securities's WST Position: Q3 2019 in Review

BB&T Securities reduced its West Pharmaceutical (WST) stake by 4.6% in Q3 2019, selling an estimated $12.1K and leaving 1,835 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

BB&T Securities first reported a position in WST in Q2 2019 and has held it in 2 quarters since. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

  • BB&T Securities held 1,835 shares of West Pharmaceutical worth $260K as of Q3 2019.
  • BB&T Securities sold 88 West Pharmaceutical shares in Q3 2019, an estimated $12.1K.
  • West Pharmaceutical made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1385 holding.
  • BB&T Securities first reported a position in West Pharmaceutical in Q2 2019 and has held it in 2 quarters since.
  • 406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.